Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KALV Kalvista Pharmaceuticals Inc

休市中 05-10 16:00:00 EDT

12.08

-0.01

-0.08%

盘后12.08

+0.000.00%

19:11 EDT

最高12.15	最低11.79	成交量21.80万
今开12.10	昨收12.09	日振幅2.98%
总市值5.10亿	流通市值2.91亿	总股本4,219万
成交额262.78万	换手率0.90%	流通股本2,412万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":12.08,"timestamp":1715371200000,"preClose":12.09,"halted":0,"volume":217954,"hourTrading":{"tag":"盘后","latestPrice":12.08,"preClose":12.08,"latestTime":"19:11 EDT","volume":7093,"amount":85670.04,"timestamp":1715382706674},"delay":0,"floatShares":24116403,"shares":42188296,"eps":-3.142869,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"05-10 16:00:00 EDT","open":12.1,"high":12.15,"low":11.79,"amount":2627781.7989060003,"amplitude":0.029777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.142869,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715587200000},"adr":0,"listingDate":1479790800000,"adjPreClose":12.09,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":11.81,"preClose":12.09,"latestTime":"09:24 EDT","volume":40,"amount":472.40000000000003,"timestamp":1715347463951},"postHourTrading":{"tag":"盘后","latestPrice":12.08,"preClose":12.08,"latestTime":"19:11 EDT","volume":7093,"amount":85670.04,"timestamp":1715382706674},"volumeRatio":1.3392691466863935},"requestUrl":"/m/hq/s/KALV","defaultTab":"news","newsList":[{"id":"2426232644","title":"Needham：重申KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426232644","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426232644?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:15","pubTimestamp":1712830514,"startTime":"0","endTime":"0","summary":"Needham：重申KalVista Pharma(KALV.US)评级，由买入调整至买入评级, 目标价35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111815198b0fb8cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111815198b0fb8cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415052943","title":"Kalvista Pharmaceuticals Inc盘中异动 快速下跌5.06%报13.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415052943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415052943?lang=zh_cn&edition=full","pubTime":"2024-02-29 01:52","pubTimestamp":1709142740,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日01时52分，Kalvista Pharmaceuticals Inc股票出现波动，股价大幅下跌5.06%。Kalvista Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃，换手率分别为5711.47%、221.29%、121.33%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc，振幅分别为424.75%、219.84%、129.29%。Kalvista Pharmaceuticals Inc公司简介：KalVista Pharmaceuticals Inc 是一家制药公司，专注于发现、开发和商业化用于一系列疾病的小分子蛋白酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229015220791594bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229015220791594bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411322694","title":"美国研究综述-布鲁克公司、Cymabay Therapeutics、SSR 矿业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411322694","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411322694?lang=zh_cn&edition=full","pubTime":"2024-02-14 15:35","pubTimestamp":1707896137,"startTime":"0","endTime":"0","summary":"    路透社2月14日 - 华尔街证券分析师周三调整了对布鲁克公司、Cymabay Therapeutics 和 SSR 矿业公司等几家美国上市公司的评级和目标价。要点             * 布鲁克公司  ：摩根大通将其评级从中性上调至增持             * Cymabay Therapeutics Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411839396","title":"嗡嗡声--美国股票走势-捷蓝航空公司、LPL Financial、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2411839396","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411839396?lang=zh_cn&edition=full","pubTime":"2024-02-14 03:25","pubTimestamp":1707852333,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月13日 - 华尔街主要股指周二下滑，触及一周低点，此前消费者通胀数据高于预期，推动美国国债收益率走高，令市场对即将降息的猜测打消。美东时间13:36，道琼斯工业平均指数  报38,133.46点，上涨1.71%。标准普尔500指数  下跌1.36%，报4,953.74点；纳斯达克综合指数  下跌1.68%，报15,675.194点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411355969","title":"更新版 1-KalVista 在遗传病后期试验中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2411355969","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411355969?lang=zh_cn&edition=full","pubTime":"2024-02-13 20:10","pubTimestamp":1707826232,"startTime":"0","endTime":"0","summary":"     路透社2月13日 - KalVista Pharmaceuticals   周二称，其治疗一种遗传性疾病的疗法在一项后期试验中达到了主要目标，这种疾病会导致皮下和身体其他部位迅速肿胀。这种名为sebetralstat的疗法显示，遗传性血管性水肿 患者开始缓解症状的速度明显快于安慰剂。使用低剂量的sebetralstat，症状开始缓解的中位时间为1.61小时，而使用安慰剂则为6.72小时。Sebetralstat在136名成人和青少年HAE患者中进行了测试，HAE是一种因缺乏某种名为C1-抑制因子的蛋白质或其功能障碍而引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kalvista.com","stockEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0126},{"period":"3month","weight":-0.245},{"period":"6month","weight":0.4969},{"period":"1year","weight":0.2415},{"period":"ytd","weight":-0.0139}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"KalVista Pharmaceuticals, Inc.于2004年3月26日在特拉华州注册成立。该公司是一家临床阶段制药公司，专注于发现、开发和商业化小分子蛋白酶抑制剂，用于有重大未满足需求的疾病。该公司运用他们对蛋白酶的化学和生物学的洞见，开发出具有高选择性、效力和生物利用度的口服疗法，该公司相信这将使它们成为治疗疾病的成功药物。该公司利用这些能力开发了针对遗传性血管性水肿（HAE）的新型小分子血浆激肽释放酶抑制剂。该公司还在进行一项新的口服XIIa因子（“XIIa因子”）抑制剂项目的临床前开发。该公司正在初步推进这一项目，以提供下一代HAE疗法，这也为将来扩展到其他未满足的高需求适应症提供了机会。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.011211},{"month":2,"riseRate":0.5,"avgChangeRate":0.168896},{"month":3,"riseRate":0.375,"avgChangeRate":-0.068789},{"month":4,"riseRate":0.375,"avgChangeRate":0.010157},{"month":5,"riseRate":0.5,"avgChangeRate":-0.023069},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.002456},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.011961},{"month":8,"riseRate":0.714286,"avgChangeRate":0.205125},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.051841},{"month":10,"riseRate":0.428571,"avgChangeRate":0.041215},{"month":11,"riseRate":0.571429,"avgChangeRate":0.052624},{"month":12,"riseRate":0.5,"avgChangeRate":0.066364}],"exchange":"NASDAQ","name":"Kalvista Pharmaceuticals Inc","nameEN":"Kalvista Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kalvista Pharmaceuticals Inc,KALV,Kalvista Pharmaceuticals Inc股票,Kalvista Pharmaceuticals Inc股票老虎,Kalvista Pharmaceuticals Inc股票老虎国际,Kalvista Pharmaceuticals Inc行情,Kalvista Pharmaceuticals Inc股票行情,Kalvista Pharmaceuticals Inc股价,Kalvista Pharmaceuticals Inc股市,Kalvista Pharmaceuticals Inc股票价格,Kalvista Pharmaceuticals Inc股票交易,Kalvista Pharmaceuticals Inc股票购买,Kalvista Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kalvista Pharmaceuticals Inc(KALV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kalvista Pharmaceuticals Inc(KALV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}